Top

Breast Cancer Research and Treatment

Published in:

01-11-2005 | Report

High Incidence of 4153delA BRCA1 Gene Mutations in Lithuanian Breast- and Breast-ovarian Cancer Families

Authors: Jacek Gronwald, Pavel Elsakov, Bohdan Górski, Jan Lubiński

Published in: Breast Cancer Research and Treatment | Issue 2/2005

Title: High Incidence of 4153delA BRCA1 Gene Mutations in Lithuanian Breast- and Breast-ovarian Cancer Families
Authors: Jacek Gronwald
Pavel Elsakov
Bohdan Górski
Jan Lubiński
Publication date: 01-11-2005
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 2/2005
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-005-5150-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2005

A Cost-effectiveness Analysis of Two Rehabilitation Support Services for Women with Breast Cancer

Mammographic Breast Density and the Gail Model for Breast Cancer Risk Prediction in a Screening Population

Serum Lipids and Outcome of Early-stage Breast Cancer: Results of a Prospective Cohort Study

Anti-estrogenic Effects of Conjugated Linoleic Acid through Modulation of Estrogen Receptor Phosphorylation

How Should We Inform Women at Higher Risk of Breast Cancer About Tamoxifen? An Approach with a Decision Guide

Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer